Diagnostic Thresholds for Methylmalonic Acid (MMA)
Introduction to MMA Interpretation
- Normal MMA levels are typically below 270-271 nmol/L, and levels above this threshold indicate functional vitamin B12 deficiency or metabolic disease, even when serum B12 levels appear normal 1, 2
- The ESPEN guideline recommends using MMA as a confirmatory test when B12 levels are indeterminate (180-350 ng/L or 25-70 pmol/L for active B12) 1, 2
Diagnostic Considerations
- MMA levels above 271 nmol/L indicate functional B12 deficiency requiring intervention, regardless of serum B12 concentration 2
- MMA should be measured as a second-line test when initial B12 testing shows indeterminate results (total B12 180-350 ng/L or active B12 25-70 pmol/L) and clinical suspicion remains 1, 3
- MMA provides more reliable functional assessment of B12 status than serum B12 alone, as it reflects actual cellular B12 availability 1, 2
Disease-Specific Considerations
- MMA elevation above 271 nmol/L combined with low or indeterminate B12 levels confirms functional deficiency requiring treatment 2
- In genetic methylmalonic acidemia, MMA levels are dramatically elevated (often >1,000 nmol/L) due to enzymatic defects in methylmalonyl-CoA mutase 5
Important Caveats
- Renal insufficiency elevates MMA independent of B12 status, making interpretation difficult in patients with kidney disease 2, 6
- MMA is more specific for B12 deficiency (98.4% specificity) compared to homocysteine, which can be elevated in folate deficiency 6
- The optimal diagnostic strategy combines at least two biomarkers: holo-transcobalamin (holo-TC) and MMA, with serum cobalamin as a replacement when holo-TC is unavailable 2